Local care and medical treatment for ischemic diabetic ulcers;Soins locaux et traitement médical des troubles trophiques ischémiques des diabétiques

Journal des Maladies Vasculaires

Volumn 27, Issue 3, 2002, Pages 157-163

  Lazareth, I ^a  

^a SAINT JOSEPH HOSPITAL   (France)

Author keywords

Diabetic foot; Granulocyte colony stimulating factor; Iloprost; Peripheral vascular disease

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CEFALEXIN; CEPHACET; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; DALACINE; GRANULOCYTE COLONY STIMULATING FACTOR; ILOPROST; OXYGEN; PIPERACILLIN PLUS TAZOBACTAM; PLATELET DERIVED GROWTH FACTOR; TEICOPLANIN; TIMENTIN;

ANALGESIA; ANGIOPLASTY; ANTIBIOTIC THERAPY; ARTERY PERFUSION; ARTICLE; BANDAGE; CELL FUNCTION; CELL PROLIFERATION; CLINICAL TRIAL; COMPRESSION THERAPY; DEBRIDEMENT; DIABETIC FOOT; DISEASE SEVERITY; ELECTROSTIMULATION; ENTEROCOCCUS; EXCISION; FOOT INJURY; GRAM NEGATIVE BACTERIUM; HUMAN; HYPERBARIC OXYGEN; LEG COMPRESSION; LEG EDEMA; LEG REVASCULARIZATION; LIMB AMPUTATION; NEUTROPHIL; PLASTIC SURGERY; SKIN GRAFT; SKIN NECROSIS; SKIN ULCER; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; ULCER HEALING; VASODILATATION; WOUND DRESSING; WOUND HEALING;

AMPUTATION; DIABETIC ANGIOPATHIES; ELECTRIC STIMULATION; FOOT ULCER; HUMANS; ISCHEMIA; SKIN ULCER;

EID: 0036628190     PISSN: 03980499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. LIPSKY BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol Med Microbiol, 1999; 26: 267-76.
2. SOMME D, RENY JL, MAINARDI JL. Troubles trophiques du pied chez le diabétique: stratégie anti-infectieuse. Ann Med Interne, 2001; 152: 305-16.
3. FRYKBERG RG, ARMSTRONG DG, GIURINI DPM et al. Diabetic foot disorders. A clinical practice: guideline. J Foot Ankle Surg, 2000; 39: s1-s60.
4. TEMPLE ME, NABATA MC. Pharmacotherapy of lower limb diabetic ulcers. J Am Geriatr Soc, 2000; 48: 822-8.
5. GOUGH A, CLAPPERTON M, ROLANDO N et al. Randomised placebo controlled trial of granulocyte-colony stimulating factor in diabetic foot infection. Lancet, 1997; 350: 855-9.
6. DE LALLA F, PELLIZZER G, STRAZZABOSCO M et al. Randomized prospective controlled trial of recombinant granulocyte colonystimulating factor as adjunctive therapy for limb-threatening diabetic foot infection. Antimicrob Agents Chem, 2001; 45: 1094-8.
7. United Kingdom Severe Limb Ischemia Study Group. Treatment of limb threatening ischemia with intravenous iloprost: a randomized double-blind placebo-controlled study. Eur J Vasc Surg, 1991; 5: 511-6.
8. LOOSEMORE TM, CHALMERS TC, DORMANDY JA. A metaanalysis of randomized placebo control trials in Fontaine stages III and IV peripheral occlusive arterial disease. Int Angiol, 1994; 13: 133-42.
9. AROSIO E, SARDINA M, PRIOR M, DE MARCHI S, ZANNONI M, BIANCHINI C. Clinical and circulatory effects of iloprost either administered for 1 week or 4 weeks in patients with peripheral obstructive arterial disease at Leriche-Fontaine stage III. Eur Rev Med Pharmacol Sci, 1998; 2: 53-9.
10. The oral iloprost in severe leg ischaemia study group. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (iloprost) in severe leg ischaemia. Eur J Endovasc Surg, 2000; 20: 358-62.
11. WUNDERLICH RP, PETERS EJG, LAVERY LA. Systemic hyperbaric oxygen therapy. Lower-extremity wound healing and the diabetic foot. Diabetes Care, 2000; 23: 1551-5.
12. ARMSTRONG DG, NGUYEN HC. Improvement in healing with aggressive edema reduction after debridement of foot infection in persons with diabetes. Arch Surg, 2000; 135: 1405-9.
13. WIEMAN TJ. Clinical efficacy of becaplermin (rhPDGF-BB) gel. Am J Surg, 1998; 176(sup2A): 74S-79S.
14. LADIN D. Becaplermin gel (pdgf-bb) as topical wound therapy. Plast Reconstr Surg, 2000; 105: 1230-1.
15. GENTZKOW GD, IWASAKI SD, HERSHON KS et al. Use of Dermagraft, a cultured human dermis, to treat diabetic foot ulcers. Diabetes Care, 1996; 19: 350-4.
16. MANSBRIDGE J, LIU K, PATCH R, SYMONS K, PINNEY E. Three-dimensional fibroblast culture implant for the treatment of diabetic foot ulcers: metabolic activity and therapeutic range. Tissu Eng, 1998; 4: 403-14.
17. VEVES A, FALANGA V, ARMSTRONG DG, SABOLINSKI ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers. Diabetes Care, 2001; 24: 290-5.
18. PETERS EJ, LAVERY LA, ARMSTRONG DG, FLEISCHLI JG. Electric stimulation as an adjunct to heal diabetic foot ulcers: a randomized clinical trial. Arch Phys Med Rehabil, 2001; 82: 721-5.
19. LAVERY LA, VELA SA, FLEISCHLI JG, ARMSTRONG DG, LAVERY DC. Reducing plantar pressure in the neuropathic foot. Diabetes Care, 1997; 20: 1706-10.